ACE inhibitors for sarcopenia - As good as exercise training?

Age and Ageing

Volumn 37, Issue 4, 2008, Pages 363-365

  Witham, Miles D ^a   Sumukadas, Deepa ^a   Mcmurdo, Marion E T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH HORMONE; INTERLEUKIN 6; PERINDOPRIL; PLACEBO; RENIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ACCIDENT PREVENTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DAILY LIFE ACTIVITY; DRUG TOLERABILITY; EDITORIAL; ELDERLY CARE; ENDURANCE; EVIDENCE BASED MEDICINE; EXERCISE; FALLING; FRACTURE; GENOTYPE; HEART OUTPUT; HUMAN; HYPERTENSION; INFLAMMATION; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MUSCLE ATROPHY; MUSCLE BLOOD FLOW; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TRAINING; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WALKING SPEED;

AGED; AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EXERCISE; HUMANS; MUSCULAR ATROPHY;

EID: 47049092979     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afn124     Document Type: Editorial

References (15)

1. Rantanen T, Avlund K, Suominen H et al. Muscle strength as a predictor of onset of ADL dependence in people aged 75 years. Aging Clin Exp Res 2002; 14:10-5.
2. Laukkanen P, Heikkinen E, Kauppinen M. Muscle strength and mobility as predictors of survival in 75-84-year-old people. Age Ageing 1995; 24: 468-73.
3. Sumukadas D, Struthers AD, McMurdo ME. Sarcopenia-a potential target for Angiotensin-converting enzyme inhibition? Gerontology 2006; 52: 237-42.
4. Kadi F, Charifi N, Denis C et al. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve 2004; 29: 120-7.
5. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev 2007; 65: S208-12.
6. Saver AA, Syddall HE, Dennison EM et al. Grip strength and the metabolic syndrome: Findings from the Hertfordshire Cohort Study. QJM 2007; 100: 707-13.
7. Montgomery H, Clarkson P, Barnard M et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999; 353: 541-5.
8. Onder G, Penninx BW, Balkrishnan R et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: An observational study. Lancet 2002; 359: 926-30.
9. Fiatarone MA, Marks EC, Ryan ND et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 1990; 263: 3029-34.
10. McMurdo ME, Rennie L. A controlled trial of exercise by residents of old people's homes. Age Ageing 1993; 22: 11-5.
11. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ et al. Androgen treatment and muscle strength in elderly men: A meta-analysis. J Am Geriatr Soc 2006; 54: 1666-73.
12. Liu H, Bravata DM, Olkin I et al. Systematic review: The safety and efficacy of growth hormone in thc hcalthy elderly. Ann Intern Med 2007; 146: 104-15.
13. Campbell PM, Allain TJ. Muscle strength and vitamin D in older people. Gerontology 2006; 52: 335-8.
14. Sumukadas D, Witham MD, Struthers AD et al. Effect of perindopril on physical function in elderly people with functional impairment: A randomized controlled trial. CMAJ 2007; 177: 867-74.
15. Nelson ME, Layne JE, Bernstein MJ et al. The effects of multidimensional home-based exercise on functional performance in elderly people. J Gerontol A Biol Sci Med Sci 2004; 59: 154-60.